Research Projects
Current projects
Showing results 401 - 410 out of 459
2003
Bretz F, Hothorn LA. Comparison of exact and resampling based multiple testing procedures. Communications in Statistics Part B: Simulation and Computation. 2003 Jan 6;32(2):461-473. doi: 10.1081/SAC-120017501
Bretz F, Hothorn LA, Hsu JC. Identifying effective and/or safe doses by stepwise confidence intervals for ratios. Statistics in medicine. 2003 Feb 21;22(6):847-858. doi: 10.1002/sim.1449
Bretz F, Hothorn LA. Statistical analysis of monotone or non-monotone dose-response data from in vitro toxicological assays. Alternatives to laboratory animals. 2003 Nov;31(SUPPL. 1):81-96. doi: 10.1177/026119290303101s06
Hauschke D, Hothorn LA. Two-stage testing of safety: A statistical view. ATLA Alternatives to Laboratory Animals. 2003 Nov;31(SUPPL. 1):77-80. doi: 10.1177/026119290303101s05
Hellmer J, Teubner A, Zeilinger C. Conserved arginine and aspartate residues are critical for function of MjNhaP1, a Na+/H+ antiporter of M. jannaschii. FEBS letters. 2003 May 8;542(1-3):32-6. doi: 10.1016/s0014-5793(03)00332-6
Hellmer J, Zeilinger C. MjK1, a K+ channel from M. jannaschii, mediates K+ uptake and K+ sensitivity in E. coli. FEBS letters. 2003 Jul 17;547(1-3):165-9. doi: 10.1016/s0014-5793(03)00706-3
Hirotsu C, Hothorn LA. Impact of the ICH E9 Guideline Statistical Principles for Clinical Trials on the Conduct of Clinical Trials in Japan. Therapeutic Innovation & Regulatory Science. 2003 Oct 1;37(4):381-395. doi: 10.1177/009286150303700405, 10.15488/3012
Hothorn LA, Wassmer G. Analyzing randomized dose finding studies with a primary and a secondary endpoint. Journal of Biopharmaceutical Statistics. 2003 Jan 4;13(2):301-305. doi: 10.1081/BIP-120019273
Hothorn LA, Bretz F. Dose-response and thresholds in mutagenicity studies: A statistical testing approach. Alternatives to laboratory animals. 2003 Nov;31(SUPPL. 1):97-103. doi: 10.1177/026119290303101s07
Hothorn LA. Statistics of interlaboratory in vitro toxicological studies. Alternatives to laboratory animals. 2003 Nov;31(SUPPL. 1):43-63. doi: 10.1177/026119290303101s03
Showing results 401 - 410 out of 459
Finished projects
Showing results 401 - 410 out of 459
2003
Bretz F, Hothorn LA. Comparison of exact and resampling based multiple testing procedures. Communications in Statistics Part B: Simulation and Computation. 2003 Jan 6;32(2):461-473. doi: 10.1081/SAC-120017501
Bretz F, Hothorn LA, Hsu JC. Identifying effective and/or safe doses by stepwise confidence intervals for ratios. Statistics in medicine. 2003 Feb 21;22(6):847-858. doi: 10.1002/sim.1449
Bretz F, Hothorn LA. Statistical analysis of monotone or non-monotone dose-response data from in vitro toxicological assays. Alternatives to laboratory animals. 2003 Nov;31(SUPPL. 1):81-96. doi: 10.1177/026119290303101s06
Hauschke D, Hothorn LA. Two-stage testing of safety: A statistical view. ATLA Alternatives to Laboratory Animals. 2003 Nov;31(SUPPL. 1):77-80. doi: 10.1177/026119290303101s05
Hellmer J, Teubner A, Zeilinger C. Conserved arginine and aspartate residues are critical for function of MjNhaP1, a Na+/H+ antiporter of M. jannaschii. FEBS letters. 2003 May 8;542(1-3):32-6. doi: 10.1016/s0014-5793(03)00332-6
Hellmer J, Zeilinger C. MjK1, a K+ channel from M. jannaschii, mediates K+ uptake and K+ sensitivity in E. coli. FEBS letters. 2003 Jul 17;547(1-3):165-9. doi: 10.1016/s0014-5793(03)00706-3
Hirotsu C, Hothorn LA. Impact of the ICH E9 Guideline Statistical Principles for Clinical Trials on the Conduct of Clinical Trials in Japan. Therapeutic Innovation & Regulatory Science. 2003 Oct 1;37(4):381-395. doi: 10.1177/009286150303700405, 10.15488/3012
Hothorn LA, Wassmer G. Analyzing randomized dose finding studies with a primary and a secondary endpoint. Journal of Biopharmaceutical Statistics. 2003 Jan 4;13(2):301-305. doi: 10.1081/BIP-120019273
Hothorn LA, Bretz F. Dose-response and thresholds in mutagenicity studies: A statistical testing approach. Alternatives to laboratory animals. 2003 Nov;31(SUPPL. 1):97-103. doi: 10.1177/026119290303101s07
Hothorn LA. Statistics of interlaboratory in vitro toxicological studies. Alternatives to laboratory animals. 2003 Nov;31(SUPPL. 1):43-63. doi: 10.1177/026119290303101s03
Showing results 401 - 410 out of 459
